(sold under the brand name Zurzuvae), the first oral medication created specifically to target . Considering that the news cycle more commonly focuses on the tragic consequences of the rarest and most extreme circumstances of (as it would for many New Yorkers ), the announcement felt like a dramatic shift.
And a necessary one: One in five mothers will experience a mood or anxiety disorder (or PMAD) during pregnancy or postpartum, around may develop postpartum depression, and are at a notably higher risk of both.But can zuranolone be a fix for these wide-ranging issues?
First, though it’s being touted as a first for postpartum depression (which, admittedly, makes for a very compelling headline), that’s not exactly true.
In 2019, the FDA approved brexanolone, which works in a very similar way but is administered via IV instead of orally. “You can imagine all of the procedural as well as logistical complications involved in going in for an IV when you’re in the postpartum period,” says New York-based reproductive psychiatrist Lucy Hutner, MD. “It’s just not the most feasible thing to do postpartum.”Zuranolone, on the other hand, appears to be a far more practical option.
Read more on glamour.com
Get the latest stars news and celebrity rumours with exclusive stories, photos, videos and interviews.
Breaking up, scandals, engagements, divorces, gossip – all you need to know about the private lives of your favorite celebs.
Get to know the latest showbiz news along with exclusive interviews and even more. All this is waiting for you on the main page 24 hours a day, 7 days a week! Who, where, when, with whom, how, why and for what!? Stay tuned to know first!
Just follow us daily and we will provide you with the current news from the life of famous stars and celebrities.
Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic
©2024. All rights reserved.